Multiple sclerosis: A study of chemokine receptors and regulatory T cells in relation to MRI variables

European Journal of Neurology

Volumn 10, Issue 5, 2003, Pages 529-535

  Putheti, P ^a,c   Morris, M ^a,b   Stawiarz, L ^a   Teleshova, N ^a   Kivisakk P ^a   Pashenkov, M ^a   Kouwenhoven, M ^a   Wiberg, M K ^a   Bronge, L ^a   Huang, Y M ^a   Soderstrom M ^a   Hillert, J ^a   Link, H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

CD4+CD25+ regulatory T cells; CXCR3; IL 10; Magnetic resonance imaging; Mononuclear cells; Multiple sclerosis; Tr cells

Indexed keywords

CD45 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; GADOLINIUM; HLA DR ANTIGEN; INTERLEUKIN 10;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; BYSTANDER EFFECT; CONTRAST ENHANCEMENT; DEMYELINATING DISEASE; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; ANALYSIS OF VARIANCE; BLOOD; CROSS-SECTIONAL STUDY; METABOLISM; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY;

ADULT; AGED; ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECEPTORS, CHEMOKINE; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES;

EID: 0142119367     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2003.00638.x     Document Type: Article

References (39)

1. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F (1999). An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190:995-1004.
2. high regulatory cells in human peripheral blood. J Immunol 167:1245-1253.
3. Barkhof F (1999). MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS). Mult Scler 5:283-286.
4. Boven LA, Montagne L, Nottet HS, De Groot CJ (2000). Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions. Clin Exp Immunol 122:257-263.
5. van Boxel-Dezaire AH, Hoff SC, van Oosten BW et al. (1999). Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann Neurol 45:695-703.
6. Calabresi PA, Tranquill LR, McFarland HF, Cowan EP (1998). Cytokine gene expression in cells derived from CSF of multiple sclerosis patients. J Neuroimmunol 89:198-205.
7. Capra R, Marciano N, Cotti Cometti V et al. (1992). Immunological and gadolinium-DTPA MRI evaluation of relapsing remitting multiple sclerosis. Acta Neurol Scand 86:342-345.
8. + T cells with regulatory properties from human blood. J Exp Med 193:1303-1310.
9. Franciotta D, Martino G, Zardini E et al. (2001). Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies. J Neuroimmunol 115:192-198.
10. Hellings N, Gelin G, Medaer R et al. (2002). Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis: association with clinical and MRI activity. J Neuroimmunol 126:143-160.
11. + T cells with regulatory properties isolated from peripheral blood. J Exp Med 193:1285-1294.
12. Khoury SJ, Guttmann CR, Orav EJ, Kikinis R, Jolesz FA, Weiner HL (2000). Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis. Arch Neurol 57:1183-1189.
13. Killestein J, Rep MH, Barkhof F et al. (2001). Active MRI lesion appearance in MS patients is preceded by fluctuations in circulating T-helper 1 and 2 cells. J Neuroimmunol 118:286-294.
14. Kivisakk P, Stawiarz L, Matusevicius D et al. (1999). High numbers of perform mRNA expressing CSF cells in multiple sclerosis patients with gadolinium-enhancing brain MRI lesions. Acta Neurol Scand 100:18-24.
15. Kraus J, Kuehne BS, Tofighi J et al. (2002). Serum cytokine levels do not correlate with disease activity and severity assessed by brain MRI in multiple sclerosis. Acta Neurol Scand 105:300-308.
16. Kurtzke J (1983). Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452.
17. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 193:1295-1302.
18. Mackay CR (2001). Chemokines: immunology's high impact factors. Nat Immunol 2:95-101.
19. + regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol 168:5979-5983.
20. McManus C, Berman JW, Brett FM, Staunton H, Farrell M, Brosnan CF (1998). MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. Neuroimmunol 86:20-29.
21. Miller DH (1994). Magnetic resonance in monitoring the treatment of multiple sclerosis. Ann Neurol 36:S91-S94.
22. van Oosten BW, Barkhof F, Scholten PE, von Blomberg BM, Ader HJ, Polman CH (1998). Increased production of tumor necrosis factor alpha, and not of interferon gamma, preceding disease activity in patients with multiple sclerosis. Arch Neurol 55:793-798.
23. Poser CM, Paty DW, Scheinberg L et al. (1983). New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231.
24. + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 5:1461-1471.
25. + T cells. J Exp Med 183:2669-2674.
26. + regulatory cells that control intestinal inflammation. J Exp Med 192:295-302.
27. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995). Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151-1164.
28. +CD8(-) thymocytes. J Exp Med 189:279-288.
29. +CD25+ suppressor T cells. J Exp Med 193:F41-F45.
30. Sindern E, Patzold T, Ossege LM, Gisevius A, Malin JP (2002). Expression of chemokine receptor CXCR3 on cerebrospinal fluid T-cells is related to active MRI lesion appearance in patients with relapsing-remitting multiple sclerosis. J Neuroimmunol 131:186-190.
31. Sorensen TL, Tani M, Jensen J et al. (1999). Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103:807-815.
32. Sorensen TL, Sellebjerg F, Jensen CV, Strieter RM, Ransohoff RM (2001). Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis. Eur J Neurol 8:665-672.
33. + T-lymphocytes in relapsing-remitting multiple sclerosis patients: a serial analysis. J Neuroimmunol 66:147-151.
34. Teleshova N, Pashenkov M, Huang Y-M et al. (2002). CCR5 and CXCR3 chemokine receptor expression on blood and CSF cells in multiple sclerosis and optic neuritis. J Neurol 248:723-729.
35. Wang HY, Matsui M, Saida T (2002). Immunological disturbances in the central nervous system linked to MRI findings in multiple sclerosis. J Neuroimmunol 125:149-154.
36. Waubant E, Goodkin DE, Gee L et al. (1999). Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology 53:1397-1401.
37. Waubant E, Gee L, Bacchetti P et al. (2001). Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS. J Neuroimmunol 112:139-145.
38. Zang Y-C, Samanta AK, Halder JB et al. (2000). Aberrant T cell migration toward RANTES and MIP-1alpha in patients with multiple sclerosis. Overexpression of chemokine receptor CCR5. Brain 123:1874-1882.
39. Zoukos Y, Kidd D, Woodroofe MN, Kendall BE, Thompson AJ, Cuzner ML (1994). Increased expression of high affinity IL-2 receptors and beta-adrenoceptors on peripheral blood mononuclear cells is associated with clinical and MRI activity in multiple sclerosis. Brain 117:307-315.